IVTEAM
Challenges of automated intravenous compounding
"We examined the scope and impact of drug shortages on the automated preparation of cytotoxic drugs and parenteral nutrition at a tertiary-level hospital" Calvo et al (2025).
Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 277-288 of 997 results.
"We examined the scope and impact of drug shortages on the automated preparation of cytotoxic drugs and parenteral nutrition at a tertiary-level hospital" Calvo et al (2025).
"To determine the prevalence of MARSI associated with peripherally inserted central venous catheters (PICCs) in oncology and haematology patients, analyse the type of injury and identify risk factors" Zaballa Canive et al (2025).
"We aimed to study the impact of certain quality improvement (QI) initiatives in reducing these infections from baseline rate of 10.5 per 1000 central line days" Kaur et al (2025).
"This study provides the first competency-based framework for medical students to prevent blood-borne pathogen occupational exposures during clinical internships" Wang et al (2025).
"Though not statistically significant, the findings suggest that the added complexity and extended duration of the modified IV pump integration process may have increased the frequency of caregiver interactions with the NICU environment, exposing immune-vulnerable NICU patients to a higher risk of infection" Nolan et al (2025).
"Although vascular access care is crucial, its quality is often unsatisfactory due to the diversity of procedures, technologies, and the need to adapt to each patient. Despite numerous improvement interventions, high complication rates and suboptimal use of these vascular devices persist" Castro-Sánchez et al (2025).
"This pilot study aims to assess the efficacy of a one-day symposium on medical students' point-of-care ultrasound skills, knowledge, and confidence" Peticca et al (2025).
"We propose a standardized central line bundle for mandatory use in clinical trials. This will help reduce variability in baseline CLABSI rates across study centers, enabling a more accurate evaluation of the benefit-risk profile of experimental therapies-especially those requiring administration via central venous catheters" Manzoni et al (2025).
"This study shows that TIVAD can remain patent without flushing. Moreover, the lack of flushing could be economically advantageous and could provide relief for patients. Therefore, a larger study of this topic is needed" Rapisarda et al (2025).
"While first-attempt success rates were similar, the dRA approach offered greater arterial pressure waveform stability and shorter hemostasis time than the conventional RA approach, without increasing complications. Thus, dRA may be a preferable option for arterial catheterization in critically ill patients" Peng et al (2025).
"This study highlights the escalating resistance patterns of CLABSI pathogens, with a consternating decline in Access- and Watch-category antimicrobial efficacy. The AWaRe framework proves invaluable in identifying critical resistance trends, demonstrating the need for targeted antimicrobial stewardship" Anand et al (2025).
"Subcutaneous edema was identified as a predictor of catheter failure. Ultrasonographic observation of subcutaneous edema at PIVC placement may be effective in preventing catheter failure occurrence" Takahashi et al (2025).
